TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Läkemedelsgruppen Sverige AB
Closing information (x1000 EUR)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
2,247
|
1,569
|
1,757 |
| Financial expenses |
4
|
1
|
1 |
| Earnings before taxes |
148
|
-60
|
77 |
| EBITDA |
155
|
-56
|
79 |
| Total assets |
386
|
356
|
313 |
| Current assets |
361
|
336
|
308 |
| Current liabilities |
236
|
196
|
174 |
| Equity capital |
109
|
108
|
133 |
| - share capital |
4
|
4
|
5 |
| Employees (average) |
25
|
20
|
20 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
28.2%
|
30.3%
|
42.5% |
| Turnover per employee |
90
|
78
|
88 |
| Profit as a percentage of turnover |
6.6%
|
-3.8%
|
4.4% |
| Return on assets (ROA) |
39.4%
|
-16.6%
|
24.9% |
| Current ratio |
153.0%
|
171.4%
|
177.0% |
| Return on equity (ROE) |
135.8%
|
-55.6%
|
57.9% |
| Change turnover |
736
|
-32
|
73 |
| Change turnover % |
49%
|
-2%
|
4% |
| Chg. No. of employees |
5
|
0
|
1 |
| Chg. No. of employees % |
25%
|
0%
|
5% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.